Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. medicare beneficiaries aged 65 years and older

Annals of the American Thoracic Society

Volumn 12, Issue 7, 2015, Pages 981-987

  Collard, Harold R ^a   Chen, Shih Yin ^b   Yeh, Wei Shi ^b   Li, Qian ^c   Lee, Yuan Chi ^c   Wang, Alan ^c   Raghu, Ganesh ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BIOGEN   (United States)

^c EVIDERA   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Cost of illness; Idiopathic pulmonary fibrosis; Medicare

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EMERGENCY WARD; FATIGUE; FEMALE; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; GERIATRIC CARE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; ICD-9-CM; LUNG CANCER; LUNG CARCINOMA; LUNG EMBOLISM; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; OXYGEN THERAPY; PNEUMONIA; PREVALENCE; PULMONARY HYPERTENSION; RANDOM SAMPLE; RESPIRATORY TRACT INFECTION; RISK FACTOR; THORAX RADIOGRAPHY; UNITED STATES; COST OF ILLNESS; DRUG COST; ECONOMICS; IDIOPATHIC PULMONARY FIBROSIS; PATIENT ATTITUDE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COST OF ILLNESS; DRUG COSTS; FEMALE; HOSPITALIZATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MEDICARE; PATIENT ACCEPTANCE OF HEALTH CARE; UNITED STATES;

EID: 84942235253     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201412-553OC     Document Type: Article

References (22)

1. Michaelson JE, Aguayo SM, Roman J. Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management. Chest 2000; 118:788-794.
2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
3. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008;3:8.
4. Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE II, Pellegrini CA. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136-142.
5. Salvioli B, Belmonte G, Stanghellini V, Baldi E, Fasano L, Pacilli AM, De Giorgio R, Barbara G, Bini L, Cogliandro R, et al. Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis 2006;38:879-884.
6. Sweet MP, Patti MG, Leard LE, Golden JA, Hays SR, Hoopes C, Theodore PR. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg 2007;133:1078-1084.
7. Tobin RW, Pope CE II, Pellegrini CA, Emond MJ, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158: 1804-1808.
8. Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 2009;136:772-778.
9. Hubbard RB, Smith C, Le Jeune I, Gribbin J, Fogarty AW. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med 2008; 178:1257-1261.
10. Collard HR, Ward AJ, Lanes S, Cortney Hayflinger D, Rosenberg DM, Hunsche E. Burden of illness in idiopathic pulmonary fibrosis. J Med Econ 2012;15:829-835.
11. Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med 2014;2:566-572.
12. Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 183:431-440.
13. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-816.
14. Bureau of Labor Statistics. Consumer Price Index. Washington, DC: Bureau of Labor Statistics, U.S. Department of Labor; 2014. Available at: http://www.bls.gov/cpi/.
15. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA, et al.; Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007;176:636-643.
16. Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 2011;37:356-363.
17. Wennberg JE, Staiger DO, Sharp SM, Gottlieb DJ, Bevan G, McPherson K, Welch HG. Observational intensity bias associated with illness adjustment: cross sectional analysis of insurance claims. BMJ 2013;346:549.
18. Lee JS, McLaughlin S, Collard HR. Comprehensive care of the patient with idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2011;17: 348-354.
19. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al.; ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370: 2083-2092.
20. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al.; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-2082.
21. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med 2011;184:159-171.
22. Yusen RD, Shearon TH, Qian Y, Kotloff R, Barr ML, Sweet S, Dyke DB, Murray S. Lung transplantation in the United States, 1999-2008. Am J Transplant 2010;10:1047-1068.